Inhibitory effects of N-(acryloyl)benzamide derivatives on tyrosinase and melanogenesis

Bioorganic & Medicinal Chemistry - Tập 27 Số 17 - Trang 3929-3937 - 2019
Sanggwon Lee1, Sultan Ullah1, Chaeun Park1, Hee Won Lee1, Dongwan Kang1, Jungho Yang1, Jinia Akter1, Yujin Park1, Pusoon Chun2, Hyung Ryong Moon1
1Laboratory of Medicinal Chemistry, College of Pharmacy, Pusan National University, Busan, 46241, South Korea
2College of Pharmacy and Inje Institute of Pharmaceutical Sciences and Research, Inje University, Gimhae, Gyeongnam 50834, South Korea

Tóm tắt

Từ khóa


Tài liệu tham khảo

Bonaventure, 2013, Pigment Cell Melanoma Res, 26, 316, 10.1111/pcmr.12080

Decker, 2006, Ang Chemie Intl Ed, 45, 4546, 10.1002/anie.200601255

Ahn, 2006, Chem Pharm Bull, 54, 281, 10.1248/cpb.54.281

Artés, 1998, Food Sci Tech Intl, 4, 377, 10.1177/108201329800400602

Bae, 2012, Eur J Med Chem, 57, 383, 10.1016/j.ejmech.2012.09.026

Ramsden, 2010, Arkivoc, 1, 260, 10.3998/ark.5550190.0011.107

Ramsden, 2009, Org Biomole Chem, 7, 3388, 10.1039/b910500j

Sánchez-Ferrer, 1995, BBA, 1247, 1

Muñoz-Muñoz, 1804, BBA, 2010, 1467

Agarwal KC. Mechanism-based biochemical standardization of resveratrol products and their uses thereof. US6414037B1; 2011.

Kidson, 1990, Exp Cell Res, 188, 36, 10.1016/0014-4827(90)90274-E

Imokawa, 1989, Invest Dermatol, 93, 100, 10.1111/1523-1747.ep12277369

Petrescu, 2000, Biochemistry, 39, 5229, 10.1021/bi000107z

Saeki, 1980, J Cell Physiol, 104, 171, 10.1002/jcp.1041040206

Ando, 2007, J Invest dermatol, 127, 751, 10.1038/sj.jid.5700683

Kumar, 2013, BioFactors, 39, 259, 10.1002/biof.1064

Arndt, 1965, JAMA, 194, 965, 10.1001/jama.1965.03090220021006

Fitzpatrick, 1966, Archi Dermatol, 93, 589, 10.1001/archderm.1966.01600230093025

Heilgemeir, 1981, Munch Med Woch, 123, 47

Kligman, 1975, Archi Dermatol, 111, 40, 10.1001/archderm.1975.01630130042004

Gonçalez, 2013, BioMed Res Intl, 2013

Breathnach, 1989, Clinics in Dermatol, 7, 106, 10.1016/0738-081X(89)90061-8

Garcia-Lopez, 1989, Acta Derm Venereol (Stockh), 143, 58

Curto, 1999, Biochem Pharmacol, 57, 663, 10.1016/S0006-2952(98)00340-2

Engasser, 1984, J A A Dermatol, 10, 1072, 10.1016/S0190-9622(84)80351-5

Fisher, 1983, Cutis, 31, 250

Romaguera, 1985, Contact Dermatitis, 12

Barcelos, 2014, Chem Med Chem, 9, 2725, 10.1002/cmdc.201402292

Gunia-Krzyżak, 2017, Bioorg Med Chem, 25, 471, 10.1016/j.bmc.2016.11.014

Spasova, 2006, J Peptide Sci, 12, 369, 10.1002/psc.736

Spasova, 2008, Bioorg Med Chem, 16, 7457, 10.1016/j.bmc.2008.06.010

Georgiev, 2013, Med Chem Res., 22, 4173, 10.1007/s00044-012-0419-x

Sova, 2012, Mini Rev Med Chem, 12, 749, 10.2174/138955712801264792

Bandgar, 2012, Bioorg Med Chem, 20, 5649, 10.1016/j.bmc.2012.07.001

Kavala, 2012, JOC, 77, 5022, 10.1021/jo300501j

Romagnoli, 2018, J Enz Inhi Med Chem., 33, 727, 10.1080/14756366.2018.1450749

Fiorino, 2012, Bioorg Med Chem, 20, 5001, 10.1016/j.bmc.2012.06.026

Goodman, 2002, Adv Syn Cat, 344, 953, 10.1002/1615-4169(200210)344:9<953::AID-ADSC953>3.0.CO;2-A

Vanderwal, 2004, JACS, 126, 14724, 10.1021/ja045563f

Do Hyun Kim, 2017, Drug Des Devel Ther, 11, 827, 10.2147/DDDT.S131538

Kim, 2018, Biorg Med Chem.

Morris, 1998, J Comp Chem, 19, 1639, 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B

Moustakas, 2006, J Comput Aided Mol Des, 20, 601, 10.1007/s10822-006-9060-4

Bagherzadeh, 2015, J Biomol Struct Dyn, 33, 487, 10.1080/07391102.2014.893203

Hyun, 2008, Biol Pharm Bull, 31, 154, 10.1248/bpb.31.154

Ishiyama, 1996, Biol Pharm Bull, 19, 1518, 10.1248/bpb.19.1518

Bae, 2013, BBA, 77, 65, 10.1271/bbb.120547

Chen, 2009, Biol Pharm Bull, 32, 1447, 10.1248/bpb.32.1447

Matos, 2015, RSC Adv, 5, 94227, 10.1039/C5RA14465E